Seshadri S, Morris G, Serhal P, Saab W
These data emphasised how GLP1RA treatment may not be effective in subsets of patients with obesity
The MHRA encourages reporting of suspected adverse drug reactions through the Yellow Card scheme (yellowcard.mhra.gov.uk), which helps monitor medication safety across the UK population
GoalBMI Wellness Pricing Insurance & Self-Pay Options GoalBMI Wellness offers free insurance verification for every patient, plus transparent self-pay pricing for those whose plans dont cover GLP-1 treatment
In new data from the ATTAIN-2 trial presented at ObesityWeek, researchers revealed the oral GLP-1 also induced similar benefits for adults with overweight or obesity and type 2 diabetes
Hepatology 53 , 18831894 (2011)